ARCHIVES

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

This article is from The Cancer Letter archive.

Vol. 27 No. 21 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975